Hostname: page-component-84b7d79bbc-5lx2p Total loading time: 0 Render date: 2024-07-26T09:27:10.543Z Has data issue: false hasContentIssue false
  • English
  • Français

Home Drug Infusion Therapy: A Literature Update

Published online by Cambridge University Press:  10 March 2009

Warren Balinsky  and
Arthur Mollin
Warren Balinsky
Affiliation:
New School for Social Research
Arthur Mollin
Affiliation:
New School for Social Research
Get access Rights & Permissions [Opens in a new window]

Abstract

This paper is a literature review and update of home drug infusion therapy (HDIT) in the United States. It concentrates on cost-effectiveness studies of parenteral antibiotic therapy administered in an outpatient setting. This update is timely because Medicare and other payors are under the pressure of cost containment with respect to this modality. Additionally, managed care is redefining reimbursement programs, which will affect HDIT in the future.

Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 14 , Issue 3 , Summer 1998 , pp. 535 - 543
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Antoniskis, A., Anderson, B. C., Van Volkinburg, E. J., et al. Feasibility of outpatient self administration of parenteral antibiotics. Western Journal of Medicine, 1978, 128, 203–06.Google ScholarPubMed
2.Balinsky, W.Home, l.V.drug therapy reimbursement. In Connors, R. B. & Winters, R. W. (eds.), Home infusion therapy: Current status and future trends. Chicago, IL: America Hospital Publishing, 1995.Google Scholar
3.Balinsky, W.Home care: Current problems and future solutions. San Francisco, CA: Jossey-Bass Inc., 1994.Google Scholar
4.Balinsky, W.Reimbursement for outpatient parenteral antibiotic therapy: Update. Review of Infectious Diseases, 1991, 13 (suppl. 2), 193–95.CrossRefGoogle ScholarPubMed
5.Balinsky, W. Home care prescription drug reimbursement: A case for intravenous antibiotics. Public Issue Report, 1986, 1–27.Google Scholar
6.Balinsky, W., & Blumengold, J.Home care integration into managed care. Caring, 1995, 6, 36–44.Google Scholar
7.Balinsky, W., & Nesbitt, S.Cost-effectiveness of outpatient parenteral antibiotics: A review of the literature. American Journal of Medicine, 1989, 87, 301–05.CrossRefGoogle ScholarPubMed
8.Barfoot, K. R., & Ross, K.Intravenous therapy at home: An overview. Home Healthcare Nurse, 1988, 4, 11–13.CrossRefGoogle Scholar
9.Brown, R. B.Selecting the patient. Hospital Practice, 1993, 28 (suppl. 1), 11.CrossRefGoogle ScholarPubMed
10.Brown, R. B.Selection and training of patients for outpatient intravenous antibiotic therapy. Reviews of Infectious Diseases, 1991, 13 (suppl. 2), 147.CrossRefGoogle ScholarPubMed
11.Chambers, M.Home infusion partners with managed care. Caring, 06 1993, 6, 54–56.Google Scholar
12.Colford, J. M., Cornelli, R. L., Ganz, W. J., et al. Home antibiotic therapy of streptococcal endocarditis: A call for a controlled trial. American Journal of Medicine, 1993, 94, 111–12.CrossRefGoogle Scholar
13.Cummings, J. E., & Weaver, F. M.Cost-effectiveness of home care. Clinics in Geriatric Medicine, 1991, 7, 4.CrossRefGoogle ScholarPubMed
14.Durack, D.Endocarditis. Hospital Practice, 1993, 28 (suppl. 2), 6–9.CrossRefGoogle ScholarPubMed
15.Durack, D. T., Karchmer, A. W., Blair, R., et al. Home intravenous antibiotic therapy. American Journal of Medicine, 1993, 94, 114–15.CrossRefGoogle ScholarPubMed
16.Fox, D. M., Anderson, K. S., Benjamin, A. E., & Dunatov, L. J.Intensive home health care in the United States: Financing as technology. International Journal of Technology Assessment in Health Care, 1987, 3, 561–73.CrossRefGoogle ScholarPubMed
17.Gainer, R. B., & Smego, R. A.Intravenous home antibiotic therapy. In The Supplement, vol. 1 (Educational Service to the Professions by HNS). Pine Brook, NJ: Health Dyne Company, 1985.Google Scholar
18.Goldberg, A. I.Home care for the chronically ill in the United States: The market oriented system. In Hollingsworth, J. R., and Hollingsworth, E. J. (eds.), Care of the Chronically and Severely III. Hawthorne, NY: Aldine de Gruyter, 1994, 75–106.Google Scholar
19.Goltz, G. S.Managed care opportunities for home infusion therapy providers. Medical Interface, 1991, 22, 23, 34, & 40.Google Scholar
20.Graham, D. R., Keldermans, M. M., Klemm, L. W., et al. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. American Journal of Medicine, 1991 (suppl. 3B), 95–100.CrossRefGoogle Scholar
21.Grizzard, M. B., Harris, G., & Karns, H.Use of outpatient parenteral antibiotic therapy in health maintenance organization. Reviews of Infectious Diseases, 1991, 13 (suppl. 2), S174–79.CrossRefGoogle ScholarPubMed
22.Handy, C. M.Home care of patients with technically complex nursing needs. Nursing Clinics of North America, 1988, 2, 315–28.CrossRefGoogle Scholar
23.Kitz, D. S., & Nash, D. B.Outpatient parenteral antibiotic therapy. HMO Practice, 1988, 3, 89–92.Google Scholar
24.Managed care update. Bronxville, NY: Medicom International Inc. 1995, 7, 6–11.Google Scholar
25.National Association for Home Care. References on home care cost-effectiveness. Washington, DC: National Association for Home Care, 1995.Google Scholar
26.New, P. B., Swanson, G. F., Bulich, R. G., & Taplin, G. C.Ambulatory antibiotic infusion devices: Extending the spectrum of outpatient therapies. American Journal of Medicine, 1991, 91, 455–61.CrossRefGoogle ScholarPubMed
27.Poretz, D. M.High tech comes home. American Journal of Medicine, 1991, 91, 453–454.CrossRefGoogle ScholarPubMed
28.Poretz, D. M.Home intravenous antibiotic therapy. Clinics in Geriatric Medicine, 1991, 4, 749–63.CrossRefGoogle Scholar
29.Rodwin, M. A.Medicine, money, and morals. New York: Oxford University Press, 1993.CrossRefGoogle Scholar
30.Rothkopf, M. M., & Askanazi, J. (eds). Intensive homecare. Baltimore, MD: Williams and Wilkins, 1992.Google Scholar
31.Sheldon, P., & Bender, M.High-technology in home care: An overview of intravenous therapy. Nursing Clinics of North America, 1994, 3, 507–19.CrossRefGoogle Scholar
32.Smith, L. G., & Rothkopf, M. M.Intravenous. In Rothkopf, M. M. and Askanazi, J. (eds.), Intensive homecare. Baltimore, MD: Williams and Wilkins, 1992.Google Scholar
33.Stiver, H. G., Trosky, S. K., Cote, D. D., & Oruck, J. L.Self-administration of intravenous antibiotics: An effective, cost-effective program. Canadian Medical Association, 1982, 127, 207–11.Google Scholar
34.Swenson, J. P.Training patients to administer intravenous antibiotics at home. American Journal of Hospital Pharmacy, 1981, 38, 1480–83.Google ScholarPubMed
35.Tice, A. D. Endocarditis: A case study. Infusion, 1995, 5–7.Google Scholar
36.Tice, A. D., Marsch, P. K., Craven, P. C., & McEniry, D. W.Home intravenous antibiotic therapy. American Journal of Medicine, 1993, 94, 114–15.CrossRefGoogle ScholarPubMed
37.U.S. Congress, Office of Technology Assessment. Home drug infusion therapy under medicare. Washington, DC: U.S. Government Printing Office, 05 1992. Publication No. OTA-H-509.Google Scholar